Medical Articles 5/14

Posted by rob on May 14, 2008 under Uncategorized | Be the First to Comment

Imatinib
resistance in a novel translocation der(17)t(1;17)(q25;p13) with loss
of TP53 but without BCR/ABL kinase domain mutation in chronic
myelogenous leukemia.

Review: recent clinical trials in epigenetic therapy.

Dup-697,
a specific COX-2 inhibitor, suppresses growth and induces apoptosis on
K562 leukemia cells by cell-cycle arrest and caspase-8 activation.